If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

  • There is currently no data for BRH

Share transactions in Remote Monitored Systems plc

9 Nov 2020 07:00

RNS Number : 5885E
Braveheart Investment Group plc
09 November 2020
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

9 November 2020

Braveheart Investment Group plc

("Braveheart" or the "Group")

Share transactions in Remote Monitored Systems plc

 

Braveheart announces that on 6 November 2020 it exercised a total of 10 million options over ordinary shares in Remote Monitored Systems plc ("RMS") at an exercise price of 0.5p per share ("the RMS Option Shares") and an aggregate cost of £50,000. Braveheart has been advised that application will be made by the directors of RMS for the RMS Option Shares to be admitted to trading on the AIM market and that dealings are expected to commence on or about 13 November 2020.

Braveheart also announces that on 5 and 6 November 2020, it sold a total of 120 million ordinary shares in RMS at a weighted average price of 2.6265p per share, realising gross proceeds of approximately £3.15 million. The net funds receivable by Braveheart are primarily intended to fund the COVID-19 test project, as required and assuming it continues to deliver the results necessary to justify continuing the project, being conducted by Paraytec Limited through to a point where it is ready for commercial launch. Following these sales, Braveheart holds 389,992,405 RMS shares, representing 25.45 per cent. of the voting rights of RMS and following the admission to AIM of the RMS Option Shares will hold 399,992,405 RMS shares, representing 25.94 per cent. of the then enlarged voting rights of RMS.

About RMS

RMS is an operating company whose ordinary shares are admitted to trading on AIM. In the year ended 31 December 2019, RMS incurred a loss before taxation of £711,942 and as at that date had net liabilities of £19,250. As at 30 June 2020 had unaudited net assets of £674,135.

 

For further information: 

 

 

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown, CEO

 

 

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge / James Hornigold

 

 

 

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Heena Karani / Lucy Williams

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBPBRTMTTMBBM
Date   Source Headline
18th May 20217:00 amRNSAppointment of Non-Executive Director
6th May 20217:00 amRNSSale of shares by PDMR
5th May 20215:21 pmRNSHolding(s) in Company
4th May 20212:06 pmRNSSecond Price Monitoring Extn
4th May 20212:01 pmRNSPrice Monitoring Extension
4th May 20217:00 amRNSFurther update re Paraytec Limited
30th Apr 20215:00 pmRNSTotal Voting Rights
15th Apr 20216:25 pmRNSReplacement: Sale of shares by PDMR
15th Apr 20215:31 pmRNSSale of shares by PDMR
14th Apr 20214:40 pmRNSSecond Price Monitoring Extn
14th Apr 20214:35 pmRNSPrice Monitoring Extension
9th Apr 20212:20 pmRNSSale of shares by PDMR
7th Apr 20214:41 pmRNSSecond Price Monitoring Extn
7th Apr 20214:36 pmRNSPrice Monitoring Extension
7th Apr 20212:05 pmRNSSecond Price Monitoring Extn
7th Apr 20212:00 pmRNSPrice Monitoring Extension
1st Apr 20217:00 amRNSSale of shares by PDMR
31st Mar 20215:00 pmRNSTotal Voting Rights
29th Mar 20212:06 pmRNSSecond Price Monitoring Extn
29th Mar 20212:00 pmRNSPrice Monitoring Extension
29th Mar 20217:00 amRNSDirectorate Change
26th Mar 20212:32 pmRNSFurther update re Paraytec Limited
25th Mar 202111:05 amRNSSecond Price Monitoring Extn
25th Mar 202111:00 amRNSPrice Monitoring Extension
19th Mar 20212:06 pmRNSSecond Price Monitoring Extn
19th Mar 20212:00 pmRNSPrice Monitoring Extension
10th Mar 20213:14 pmRNSHolding(s) in Company
5th Mar 20217:05 amRNSSale of shares by PDMR
5th Mar 20217:00 amRNSReplacement: Exercise of Options & Block Admission
3rd Mar 20214:29 pmRNSExercise of Options & Block Admission application
2nd Mar 20217:00 amRNSHolding(s) in Company
1st Mar 20217:00 amRNSFurther update re Paraytec Limited
22nd Feb 20214:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20214:36 pmRNSPrice Monitoring Extension
22nd Feb 20212:05 pmRNSSecond Price Monitoring Extn
22nd Feb 20212:00 pmRNSPrice Monitoring Extension
22nd Feb 202111:05 amRNSSecond Price Monitoring Extn
22nd Feb 202111:00 amRNSPrice Monitoring Extension
18th Feb 20214:41 pmRNSSecond Price Monitoring Extn
18th Feb 20214:36 pmRNSPrice Monitoring Extension
16th Feb 202110:34 amRNSShare price movement
2nd Feb 20214:38 pmRNSHolding(s) in Company
2nd Feb 20212:28 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSFurther update re Paraytec Limited
25th Jan 202111:20 amRNSHolding(s) in Company
20th Jan 20214:40 pmRNSSecond Price Monitoring Extn
20th Jan 20214:35 pmRNSPrice Monitoring Extension
18th Jan 20214:01 pmRNSHolding(s) in Company
6th Jan 20214:41 pmRNSSecond Price Monitoring Extn
6th Jan 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.